Mostrando 2 resultados de: 2
Streamlining breast cancer and colorectal cancer biosimilar regulations to improve treatment access in Latin America: an expert panel perspective
ReviewAbstract: In a multiday conference, a panel of Latin American experts in biological cancer therapies and healtPalabras claves:Autores:Castro Sanchez N., Enrique Terán, Espinoza M.A., Gomez H.L., Hannois D., Lema M., Mantilla W., McElwee E., Rico-Restrepo M., Valdivieso N.Fuentes:googlescopusSurvival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting
ArticleAbstract: Cytogenetic abnormalities (CA) such as t(4;14), t(14;16), and del(17p), are associated with a poor pPalabras claves:Chromosome aberrations, Hematopoietic stem cell transplantation, Multiple myeloma, SurvivalAutores:Abello V., Aranda S., Beltrán C., Bove V., Cantero-Fortiz Y., Cantú-Martínez O., Cardemil D., Cardenas K.M.G., Chandía M., Contreras C., Corzo A., Cruz-Mora A., David Garrido, Donoso J., Duarte P.J., Espinoza M., Fantl D., Fernández V., García C., García-Navarrete Y.I., Gaviria L., Gazitúa R., Gomez R., Gómez-Almaguer D., Henao-Uribe A., Hopkins C.R., Idrobo H., La Rocca G., León P., López-Vidal H., Lopresti S., Mantilla W., Martínez-Cordero H., Mite A., Molina A., Ochoa P., Orlando S., Osorio R., Osuna M., Pacheco M., Peña C., Quintero G., Quiroga L., Ramírez F., Ramirez J., Remaggi G., Reyes I., Riva E., Roa M., Ruiz-Argüelles G.J., Saavedra D., Sabando B., Schulz J., Schutz N., Shanley C., Slavutsky I., Sossa C., Soto P., Tarín-Arzaga L., Torres V., Verduga A., Vergara C.G., Verri V., Yantorno S., Zabaljauregui S.Fuentes:scopus